To build trust in specialized medicine like theranostics, companies must understand and cater to the unique needs of all stakeholders, including nuclear medicine technicians and billing departments, not just the referring physicians and patients.
True scaling of complex treatments goes beyond logistics. It requires building flexibility into the system to accommodate patients' variable health, reducing the emotional and financial burden of travel for them and their families.
The primary barrier to scaling specialized treatments like theranostics is not technology but a shortage of trained technicians. Individual companies cannot succeed without taking collective, industry-level responsibility for building the necessary talent pipeline through education.